Skip to content

Clinical Study on Clear Fire Gingival Protection Toothpaste

Clinical study on reducing gingival inflammation and inhibiting dental plaque with Qinghuo Huguang Toothpaste - Clinical study on reducing gingival inflammation and inhibiting dental plaque with Qinghuo Huguang Toothpaste

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092528
Enrollment
Unknown
Registered
2024-11-18
Start date
2024-11-28
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival inflammation

Interventions

Experimental group:The test group used the toothpaste containing potassium glycyrrhizinate, and other ingredients included sorbitol, water, hydrated silica, sodium lauryl sulfate, essence, cellulose g
Control group:The control group used the toothpaste without potassium glycyrrhizinate, and the other ingredients included sorbitol, water, hydrated silica, sodium lauryl sulfate, essence, cellulose gu

Sponsors

Third Affiliated Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Good overall health condition and no systemic diseases; 2) Both males and females are welcome, aged between 18 and 60 years old; 3) There are more than 20 natural teeth, no extensive restorations in the neck of the teeth, no untreated cavities in the teeth, no severe gum recession, and no severe gum recession Periodontal disease; 4) Improved Quigley Hein plaque index>= 1.0; 5) Loe Silness gingivitis index >= 1.0, bleeding index >= 1.0 or (BOP% >= 50%); 6) No history of allergies to the ingredients of the experimental toothpaste; 7) Sign informed consent form, comply with trial rules and requirements, and complete a 4-month clinical trial.

Exclusion criteria

Exclusion criteria: 1) Currently participating in clinical trials in other dental specialties. 2) Currently pregnant, breastfeeding, or having a pregnancy plan within the trial period. 3) Teeth have extensive restorations, suspected pulpitis, dental caries, enamel cracks, and removable partial dentures. 4) Late stage of periodontal disease or received periodontal treatment (including periodontal surgery) within the past year. 5) Take anti-inflammatory, antibacterial, or statin drugs during the trial period. 6) Those who wear full mouth or removable partial dentures or orthodontic appliances. 7) More than 6 subjects with severe staining on the tooth surface during testing. 8) Patients with diabetes. 9) Allergies to any ingredients of the research product. 10) Take dietary supplements (such as multiple vitamins, antioxidants, fish oil, etc.). 11) Use antibiotics within two weeks before the start of the experiment.

Design outcomes

Primary

MeasureTime frame
Gingival Index (GI);Bleeding Index (BI);Plaque Index (PI);

Countries

China

Contacts

Public ContactXiaomian Wu

Third Affiliated Hospital of Southern Medical University

wuxiaomian898@163.com+86 158 2316 6266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026